Back to Insights
ArticleMay 18, 20265 min read

Strategy before registration: the right order for plant variety IP

Registration executes a strategy. Run the two in the wrong order and you pay for rights you do not need while missing the ones that matter.

By Tomer Biran, Founder of Greenstone

If you are filing plant variety rights before you have decided how the variety will be produced, sold, and licensed, you are paying for the wrong protection in the wrong order. Registration is how you execute a commercial plan; it cannot stand in for having one. Get the sequence right and every filing earns its place. Get it backwards and you spend budget on rights you will never use while the territories that decide your revenue are filed late, or not at all.

This is one of the simplest positioning points we work through with clients, and one of the most consistently ignored across the industry. Strategy first. Then registration.

Why "register everywhere" feels safe and is not

The instinct is understandable. A new variety is valuable, the breeding took years, and protection feels like insurance. So the default becomes "file widely and worry about the rest later." The problem is that a plant variety right is only worth something where three things line up: you intend to produce or sell there, you can build a route to market there, and you are prepared to act if someone infringes there. A right in a market you will never enter protects nothing. It only adds a recurring cost.

Filing widely also creates a false sense of security, and it usually spends money in the wrong place. The individual filing fees are rarely the problem: a plant variety right at EU level costs in the region of €900 to €1,500 to secure, modest next to the €30,000 to €50,000 a European patent can accumulate over its life (AFBV, 2026). The expense that hurts is paying renewals on rights you never use, and arriving late in the markets that count.

A portfolio of twenty registrations can look impressive and still tell you nothing about whether the variety is defensible where it actually sells.

What the strategy decides before a single filing

A commercial strategy answers the questions that registration alone cannot. Where will the variety genuinely be grown and sold, in what order, and on what timeline. Which markets are launch markets and which are later. What the licensing model will be, club, master licence, open, or a hybrid, because the model changes who needs to be bound and where. Who the partners are, and whether your protection needs to reach the propagator, the grower, the packer, or the shelf. Only once those answers exist can registration do its job, which is to put the right protection in the right place at the right moment.

Sequencing matters as much as scope. Priority windows, denomination clearance, and national formalities all run on timelines that do not forgive a late decision. Some jurisdictions make this concrete: China, for example, generally will not accept a foreign technical examination and requires the variety to be tested locally, which can add a year or more before a right is in place. Deciding late that China matters can cost a full season. The strategy is what tells you which filing has to happen now to hold a window, and which can wait until a market is real.

The cost of getting the order backwards

A breeder in the Netherlands came to us having already filed in fifteen countries for a promising new variety. The filings were technically sound. The problem was commercial: more than half were in markets the business had no realistic plan to enter, the two territories where the variety was actually being trialled at scale had been filed late and were now exposed, and the denomination had not been cleared against an existing trademark in one of the launch markets. None of that showed up on the filing schedule. It showed up the moment the commercial plan was written down, after the money had been spent.

We could not undo the spend. What we could do was re-sequence everything around the real plan, fix the denomination conflict before launch, and stop the bleed on renewals that served no purpose. The lesson the client took away was the one worth keeping: the filing schedule had looked like a strategy, so nobody had written the actual strategy down.

Contrast that with how it works when the order is right. A title holder in the UK came to us wanting to move a variety into China and parts of Asia. Rather than file broadly, we started with the commercial question, who would produce, who would distribute, and how the rights would be enforced in practice, then used our network on the ground to line up the partner before the filing strategy was set. The registration followed the plan. It protected exactly what the business intended to build, and nothing it did not.

How to put strategy first in practice

You do not need a hundred-page document. You need clarity on a short list of things before you file:

  • Where the variety will genuinely be produced and sold, ranked by priority and timing.
  • The licensing model, and therefore who in the value chain your protection has to reach.
  • The denomination and any trademark, cleared and coordinated with the filing plan.
  • The realistic enforcement picture in each priority market, because a right you will not enforce protects nothing in practice.

With those settled, registration becomes execution. Efficient filings, in the right territories, in the right order, catching denomination and formality issues before they become blockers. That is the whole point of doing it in this sequence: in our experience, the strategy tends to make the registration cheaper and stronger at the same time.

The registration stage is rarely where value is won or lost; the choices before it are. Make the filing the last step of a commercial plan, and the rights you end up with are the ones the business actually needs.

Frequently asked questions

Should I file for plant variety rights before I have a commercial strategy?

It depends on the business and the objective. In our experience, most clients are better served settling the commercial plan first, because filing early can lock in cost and territory choices before you know how the variety will be produced, sold, and licensed. That said, some businesses file early on purpose, for instance to secure a priority date as part of a deliberate strategy. Our point is simply that the filing should follow a plan rather than stand in for one.

Does filing in more countries give me stronger protection?

In our opinion, not on its own. A right tends to be worth most where you intend to produce, sell, or licence, and where you are prepared to enforce. Depending on the model, broad early filing can be the right move; more often, in our experience, filing everywhere spreads budget thin and leaves the territories that matter under-protected or filed late.

What happens if I register first and set strategy later?

In our experience this often surfaces gaps that are costly or hard to fix later, such as a missed priority window, a denomination clash, a key market left out, or filings in markets the business later exits. It is not always a problem, but re-sequencing after the fact usually costs more than getting the order right at the start.

What should come first, the variety name or the filing?

In our view both belong in the strategy. We generally suggest clearing the denomination and any trademark and coordinating them with the filing plan, since a name problem found after filing can delay or complicate a launch in an important market.

Book a free 30-minute session

About to file, or already filed and unsure the strategy underneath holds? In a free 30-minute session, we will give you a straight commercial read.

A free, no-obligation 30-minute call. We use your details only to arrange it. What this session is, and is not, is set out in our terms.

Related topics

plant variety rightsIP strategyPVRregistrationcommercialisationbreedersUPOV

More insights

Tomer Biran

About the author

Tomer Biran, Founder of Greenstone

Tomer Biran is the founder of Greenstone. He has spent more than twenty years on both sides of the table: as a qualified lawyer and former General Counsel to international organisations across multiple jurisdictions, and as a founder and operator of B2B and B2C businesses across the UK, EU, and US. He has served as General Manager of a leading plant breeders' company with a global footprint and as General Counsel of an international fresh produce marketing group. He holds a Master of Law and Business from WHU and Bucerius Law School in Hamburg, where he was a Joachim Herz Excellence Scholar, and a Bachelor of Laws. That blend of commercial operating experience and legal depth is what drives Greenstone's commercial-first approach to plant variety rights and commercialisation.

Connect on LinkedIn